Supporting Aging Through Green Exercise (SAGE) (SAGE)

January 25, 2024 updated by: Teresa Liu-Ambrose, University of British Columbia

Supporting Aging Through Green Exercise (SAGE): Comparing the Cognitive Effects of Outdoor Versus Indoor Exercise Among Older Adults With Mild Cognitive Impairment

Aerobic exercise is an evidence-based approach to mitigate cognitive decline in older adults with mild cognitive impairment (MCI). Emerging evidence suggests that the cognitive benefits of exercise may be enhanced when performed in outdoor, natural settings, as compared to indoor or built settings. Thus, the investigators aim to compare the effects of outdoor versus indoor walking programs on cognitive function among older adults with MCI. Secondary outcomes are motor function, emotional well-being, health-related behaviours, and quality of life. Participants will be randomly assigned to a 12--week, 3x/week program of either outdoor walking on forest trails or indoor walking on a treadmill. A 3-month followup will also be completed after trial completion.

Study Overview

Detailed Description

Study Design: A 12-week, single-blinded, trial with two experimental arms. Participants will be randomized (1:1) to either outdoor walking (OP) or indoor walking or cycling (IP). Measurement will occur in person at baseline and at trial completion. Additionally, follow-up measurement of questionnaire-based outcomes will occur via email or phone at 3 months following trial completion. Outcome assessors will be trained by the research team and blinded to group allocation of the participants.

Participants: 68 community-dwelling adults aged 65-80 years old with probable MCI and in sufficient health to participate in aerobic exercise of moderate intensity

Interventional Arms: All participants will receive three group-based training sessions per week for 12 weeks, under the supervision of instructors with a relevant background and first aid certification. Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. For both OP and IP, aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of their heart rate reserve (HRR) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. OP participants will walk or jog a pre-determined route in trails of an urban forest (Pacific Spirit Park). IP participants will walk or jog on treadmills in the Exercise Prescription Suite of the Centre for Hip Health and Mobility (CHHM). Both OP and IP training groups will have a participant to instructor ratio of 3:1. To promote adherence to the exercise program, sessions will be offered at times that are convenient for each individual participant. Protocols will be adjusted as necessary to align with COVID-19 guidelines.

Measurement of descriptors and outcomes: Standardized protocols will be developed and study personnel will be trained. Assessors will be blinded to treatment allocation. We will measure descriptors and outcomes at baseline and at trial completion. Each measurement session will be 2 hours in duration. For these measurements, participants will complete a session of behavioural and clinical testing at the VCH Research Pavilion and the CHHM. To account for time-of-day effects, each participant's session start time will be the same at both timepoints, and the order of the assessments will be the same for all participants.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z1M9
        • University of British Columbia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 80 years (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. achieve a score ≥18/30 and ≤24/30 on the Montreal Cognitive Assessment
  2. have subjective cognitive impairment based on interview
  3. have no significant impairment in daily function, as determined by a score ≥6/8 on the Lawton and Brody Instrumental Activities of Daily Living Scale
  4. no diagnosis of dementia
  5. aged 65 to 80 years old
  6. live independently in their own home
  7. live in the Greater Vancouver area
  8. read, write, and speak English with acceptable visual and auditory acuity
  9. are cleared to start a supervised exercise programme based on the Physical Activity Readiness Questionnaire for Everyone
  10. able to walk independently
  11. able to provide informed consent

Exclusion Criteria:

  1. participating in regular moderate to vigorous intensity aerobic exercise in the last 3 months
  2. planning to enroll in a concurrent exercise or drug trial targeting cognitive function
  3. diagnosed with a neurological, cerebrovascular, or psychiatric disease, or other chronic medical condition requiring intensive treatment and monitoring
  4. have major impairments in eyesight, hearing or motor movements
  5. have clinically significant neuropathy or musculoskeletal or joint disease
  6. have a recent traumatic brain injury, including concussions
  7. are currently using prescribed cognitive intervention or electromagnetic stimulation
  8. at the time of recruit, indicate they recently (within the last 2 months) or will start taking drugs that significantly alter cognition, movement, or affect, such as cholinesterase inhibitors, anticholinergics, hormone replacement therapy, or antidepressants

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Aerobic Exercise Indoors
Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog on treadmills or cycle on stationary bikes in the Exercise Prescription Suite of the Centre for Hip Health and Mobility.
Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog on treadmills or cycle on stationary bikes in the Exercise Prescription Suite of the Centre for Hip Health and Mobility.
Experimental: Aerobic Exercise Outdoors
Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. participants will walk or jog pre-determined routes in trails of an urban forest (Pacific Spirit Park).
Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog pre-determined routes in trails of an urban forest (Pacific Spirit Park)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Digits Span Forwards and Backwards
Time Frame: Baseline to 12 weeks
This is a measure of working memory.
Baseline to 12 weeks
Change in List Sorting Performance
Time Frame: Baseline to 12 weeks
This is a measure of working memory
Baseline to 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Digit Symbol Substitute Test
Time Frame: Baseline to 12 weeks
A measure of processing speed and executive functions.
Baseline to 12 weeks
Change in the Short Physical Performance Battery
Time Frame: Baseline to 12 weeks
A measure of balance and mobility
Baseline to 12 weeks
Change in Timed Up and Go Test
Time Frame: Baseline to 12 weeks
A measure of general mobility
Baseline to 12 weeks
Change in State-Trait Anxiety Inventory
Time Frame: Baseline to 12 weeks and 6 months
A measure of anxiety
Baseline to 12 weeks and 6 months
Change in Centre for Epidemiological Studies Depression Scale
Time Frame: Baseline to 12 weeks and 6 months
A measure of depressive symptoms
Baseline to 12 weeks and 6 months
Change in Blood Pressure
Time Frame: Baseline to 12 weeks
Systolic and diastolic blood pressure
Baseline to 12 weeks
Change in sensor measured sleep
Time Frame: Baseline to 12 weeks
Using MotionWatch 8 to measure sleep quality
Baseline to 12 weeks
Change in sensor measured physical activity
Time Frame: Baseline to 12 weeks
Using MotionWatch 8 to measure levels and amount of physical activity
Baseline to 12 weeks
Change in Physical Activity Scale for the Elderly
Time Frame: Baseline to 12 weeks and 6 months
A self-report measure of physical activity, higher scores indicate higher activity
Baseline to 12 weeks and 6 months
Change in Pittsburgh Sleep Quality Index
Time Frame: Baseline to 12 weeks and 6 months
A self-report measure of sleep quality, higher scores indicate poorer sleep quality
Baseline to 12 weeks and 6 months
Change in ICEpop CAPability measure for Older people (ICECAP-O)
Time Frame: Baseline to 12 weeks and 6 months
A measure of quality of life, higher values indicate better quality of life
Baseline to 12 weeks and 6 months
5-level EuroQoL 5-dimension (EQ-5D-5L) questionnaire
Time Frame: Baseline to 12 weeks and 6 months
A measure of quality of life, higher values indicate better quality of life
Baseline to 12 weeks and 6 months
Change in NIH Toolbox Cognitive Battery Performance
Time Frame: Baseline to 12 weeks
Measures different cognitive domains, with a focus on executive functions
Baseline to 12 weeks
Change in gait speed, derived from Short Physical Performance Battery
Time Frame: Baseline to 12 weeks.
A measure of walking speed.
Baseline to 12 weeks.
Changes in hemodynamics of the brain as measured by fNIRS during the N-Back Task
Time Frame: Baseline to 12 weeks.
A measure of brain function.
Baseline to 12 weeks.
Changes in Feeling Scale
Time Frame: Baseline to 12 weeks.
Measure of affective valence
Baseline to 12 weeks.
Changes in Exercise Enjoyment Scale
Time Frame: Baseline to 12 weeks.
An affective measure
Baseline to 12 weeks.
Changes in Felt Arousal Scale
Time Frame: Baseline to 12 weeks
Measure of affective activation
Baseline to 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Teresa Liu-Ambrose, PhD, University of British Columbia
  • Principal Investigator: Matthew Noseworthy, BSc, University of British Columbia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 19, 2022

Primary Completion (Actual)

July 10, 2023

Study Completion (Actual)

November 27, 2023

Study Registration Dates

First Submitted

September 1, 2021

First Submitted That Met QC Criteria

September 1, 2021

First Posted (Actual)

September 5, 2021

Study Record Updates

Last Update Posted (Estimated)

January 29, 2024

Last Update Submitted That Met QC Criteria

January 25, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Aerobic Exercise Indoors

3
Subscribe